Journal Article

Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study

Royer, Pierre-Yves, Mercier, Julien, Chirouze, Catherine, Klopfenstein, Timothée, Pierron, Alix, Bouiller, Kévin, Bouvier, Elodie, Gendrin, Vincent, Tipirdamaz, Can, Zayet, Souheil, Kadiane-Oussou, N’dri-Juliette, Osman, Molka, Lepiller, Quentin, Garnier, Pauline, Toko, Lynda

2022

Overview

Background. Long-term evolution data of olfactory disorders (OD) in COVID-19 are limited. Method. ANOSVID is a retrospective study in Nord Franche-Comté Hospital (France) that included COVID-19 patients from the first wave. The aim was to describe OD evolution, especially in patients with persistent OD (p-OD group) in comparison with patients with resolved OD (r-OD group). Results. Among 354 COVID-19 patients, 229 reported OD were included. Eighty-five percent of patients (n = 195) recovered from their OD within 90 days. However, 9.5 months (in average) after symptoms onset, OD were persisting in 93 patients (40.6%) and resolved in 136 patients (59.4%). In the p-OD group (n = 93), the mean age was 51.4 years (19–98) ± 20.2, and 65 patients (69.9%) were female; the three main comorbidities in the p-OD group were: asthma (20.4%, n = 19), allergic rhinitis (19.4%, n = 18), and arterial hypertension (16.1%, n = 15). Eleven patients (12%) presented anosmia, and 82 patients (88%) presented hyposmia. Asthma was more described in p-OD group than r-OD group (19 (20.4%) versus 10 (7.4%), p = 0.006). Cacosmia was more described in p-OD group than r-OD group (27 (29.0%) versus 18 (13.2%), p = 0.005). There was no significant difference between the two groups concerning other comorbidities and symptoms, clinical, biological, and imaging findings, and outcome or about the impact of OD on the quality of life of the patients between the p-OD group and r-OD group. sQOD-NS brief version score was 10.7 ± 5.89 and 12.0 ± 6.03, respectively (p = 0.137). Conclusion. Forty-one percent of patients with OD reported OD persistence 9.5 months after COVID-19 (hyposmia in 88% of cases). Asthma and cacosmia could be predictive factors of OD persistence.

• Publisher: MDPI AG,MDPI
• Subject: Allergic rhinitis / Anosmia / Asthma / Asymptomatic / cacosmia / Comorbidity / Coronaviruses / COVID-19 / Creatinine / Disease / Dyspnea / Evolution / Hypertension / Infections / Olfaction / olfactory dysfunction / Patients / Quality of life / Questionnaires / Rhinitis / Severe acute respiratory syndrome coronavirus 2 / severity / Signs and symptoms / Viral diseases